Tumors 6 and 7 both had minimal intra-tumor variation in Ki67 expression (approximately 0–10%); however, the most impactful result from these samples was highlighted in tumor #8, which was found to have a wide-range in expression of Ki67 positive cells (~30–60%). This evidence concerns the gene MKI67 and neoplasm.